Is VB a Good Investment? The Case For and Against (2026)
Last updated November 2026
Short answer
The case for VB is simple: low-cost, diversified exposure to Morningstar US small-cap index (replaced the CRSP US Small Cap Index in 2026) at a 0.03% expense ratio, anchored by names like NTRA, P, MRNA. If that is the exposure you want and you do not already own most of it through another fund, VB is a strong core holding. The trade-offs are concentration in its top names and overlap with broad-market funds you may already hold. Whether it is a buy comes down to whether you want Morningstar US small-cap index (replaced the CRSP US Small Cap Index in 2026) and at what cost. Not a recommendation; Walnut is not an investment adviser.
What are you buying with VB?
VB tracks a Morningstar US small-cap index, holding more than a thousand small-cap US companies at a 0.03% expense ratio. Vanguard renamed it the Vanguard Morningstar Small-Cap ETF in 2026 when it moved the fund off the CRSP US Small Cap Index. The key nuance versus IJR and IWM is breadth and cost: VB owns a wide, market-cap-weighted slice of small-cap America and is among the cheapest funds in the category.
Largest holdings (approximate as of November 2026; verify on Vanguard's fund page):
What's the case for VB?
VB is the Vanguard Morningstar Small-Cap ETF (renamed in 2026 from Vanguard Small-Cap ETF), which now tracks a Morningstar US small-cap index instead of the CRSP US Small Cap Index, at a 0.03% expense ratio. It holds more than a thousand small-cap US stocks (names like Natera, Everpure, Moderna, and EMCOR Group as of November 2026) in a market-cap-weighted, deeply diversified portfolio where the top ten positions are only about 4.5% of assets. Its distinguishing trait versus iShares Core S&P Small-Cap (IJR) and the Russell 2000 (IWM) is a broad, cheaper mandate that makes VB a core small-cap holding.
In its favour: it gives you Morningstar US small-cap index (replaced the CRSP US Small Cap Index in 2026) exposure in one ticker at a 0.03% expense ratio, which is simple to hold and cheap to own.
What should you weigh before buying VB?
- Cost vs alternatives: 0.03% is the fee; compare it to funds tracking a similar index.
- Concentration: check how much of VB sits in its largest holdings (NTRA, P, MRNA).
- Overlap: if you already own a broad-market fund, you may already hold much of this.
- Tracking scope: VB only gives you Morningstar US small-cap index (replaced the CRSP US Small Cap Index in 2026); it will not capture what sits outside that index.
How concentrated is VB?
“Diversified” is the word every index fund uses and it hides a wide range. The number that actually matters is how much of the fund sits in its largest positions, because that is the part that drives the return. In VB, the three largest positions are about 1.7% of the fund and the 10 largest are about 4.5%, with the single biggest at roughly 0.7%. Those are approximate weights as of November 2026, and because this is only the published top 10, treat 4.5% as a floor on concentration. The full book could be more concentrated. Verify with Vanguard.
VB is a well spread fund. No small group of names drives it, so the return will track its index closely.
The same number decides whether VB adds diversification to your portfolio in particular. A fund can be well spread on its own and still concentrate you further, if its largest holdings are names you already own directly or through another fund. Answering that means looking at your account as well as at VB, and it is the question to settle before you buy.
What VB does not give you
A fund is defined as much by what it leaves out as by what it holds, and the exclusions are rarely on the marketing page. VB tracks Morningstar US small-cap index (replaced the CRSP US Small Cap Index in 2026), so anything outside that index is simply absent from your portfolio no matter how much of the fund you own.
In practice that means checking three gaps. Whether the geography you want is covered, since a US index holds no international companies and a developed-markets index holds no emerging ones. Whether the size band you want is covered, because a large-cap index excludes the smaller companies some investors specifically want exposure to. And whether the asset class you want is covered at all, since an equity fund holds no bonds and gives you nothing to rebalance against in a drawdown.
None of these are faults; the fund is doing what it says. The mistake is assuming that owning a diversified fund means being diversified, when it means being diversified within one index.
When VB is the wrong choice
Some specific cases where it does not fit:
- You already own most of it. If a broad-market fund you hold already contains NTRA, P, MRNA at meaningful weight, adding VB mostly increases your exposure to the same companies while adding a second fee. Overlap like this is the single most common way people accidentally concentrate.
- You want the exposure for a short horizon. An index fund is a way to own an asset class over years. Over months it is simply the index, with all of the index's volatility and none of the compounding that makes holding it worthwhile.
- You need income you can rely on. Distributions from an equity index fund vary with what the underlying companies pay, so they are not a schedule you can plan around the way a bond ladder is.
- A cheaper fund tracks the same thing. Where two funds follow a similar index, the difference in expense ratio is one of the few advantages available to you without taking extra risk. Compare before assuming 0.03% is competitive.
How do you decide if VB is a buy?
The useful question is rarely “will VB go up?” It is “does this exposure fit my plan, at a cost I am happy with, without doubling up on what I already own?” Walnut connects your real brokerage so you can see exactly how VB would overlap with your current holdings, analyze it by chatting through Claude or ChatGPT, and place any trade yourself. You stay in control.
The bottom line on VB
The bottom line: VB is a low-cost core building block for Morningstar US small-cap index (replaced the CRSP US Small Cap Index in 2026) exposure, not a tactical bet on a single name. If you want Morningstar US small-cap index (replaced the CRSP US Small Cap Index in 2026) exposure and the 0.03% fee is competitive for you, it does its job well. If you already own that exposure through another fund, adding it mostly doubles a fee without adding diversification. Decide from your goal and your existing holdings, not from where the market sat last week. Walnut is not an investment adviser.
More on VB
- What is VB? (holdings, cost, performance, and the themes it covers)
- VB dividend: yield and schedule
- VB forecast: what analysts expect for its holdings
Your questions about VB
Ask Walnut's AI anything about VB and see how it fits what you own.
FAQ
Is VB a good ETF to buy?
+
Walnut is informational, not investment advice. Whether VB fits depends on your goals, time horizon, and what you already hold. It tracks Morningstar US small-cap index (replaced the CRSP US Small Cap Index in 2026) at a 0.03% expense ratio, so the questions that matter are whether you want that exposure, whether you already own it through another fund, and whether the cost is competitive for what it does.
What does VB actually hold?
+
VB tracks Morningstar US small-cap index (replaced the CRSP US Small Cap Index in 2026). Its largest positions include NTRA, P, MRNA, RVMD, ILMN and others (approximate, verify on Vanguard's fund page). The holdings are what you are really buying, not the ticker.
What is VB's expense ratio?
+
0.03% as of November 2026. Over decades, the expense ratio is one of the few things you can control, so compare it against close alternatives that track a similar index.
Does VB pay a dividend?
+
VB distributes a dividend with an approximate yield of 1.26% (November 2026). See the VB dividend page for how distributions work. Verify the current figure with Vanguard.
What are the risks of buying VB?
+
Like any index ETF, weigh concentration (how much sits in the top holdings), overlap with funds you already own, and whether Morningstar US small-cap index (replaced the CRSP US Small Cap Index in 2026) matches the exposure you actually want. VB only gives you Morningstar US small-cap index (replaced the CRSP US Small Cap Index in 2026), not what sits outside it.
How do I decide if VB is right for me?
+
Start from your goal, then check four things: what VB holds, its cost versus alternatives, how much it overlaps with what you already own, and whether the exposure fits your time horizon and risk tolerance. Walnut can analyze the overlap against your real holdings; you keep your broker and approve any trade.
Walnut is informational, not investment advice. Figures are approximations stamped to November 2026; verify current data with Vanguard or your broker. Nothing here is a recommendation to buy, sell, or hold any security.